Lenalidomide
Ended Awarded Last action
- Contract number
- 36C26125N0755
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $19,746
Award facts
- Contract value 100% obligated
- $19,746.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 awarded a delivery order contract to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide, a pharmaceutical product used in cancer treatment and immunotherapy applications. This firm fixed-price delivery order, awarded on September 23, 2025, carries a ceiling value of $19,746.09 and is scheduled for completion by October 23, 2025. The contract utilizes no set-aside designation, allowing Exelan to compete openly in this unrestricted procurement. The work will be performed in Boca Raton, Florida, where Exelan maintains its primary operations.
Exelan Pharmaceuticals Inc., a foreign-owned pharmaceutical company specializing in manufacturing, distributing, and repackaging generic and branded pharmaceutical products, is the prime contractor on this award. This delivery order falls under the company's Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), through which Exelan provides bulk drug repackaging and distribution services to federal healthcare systems including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. Exelan holds numerous indefinite delivery contracts with the VA National Acquisition Center and Defense Logistics Agency, and this Lenalidomide delivery order represents a specific pharmaceutical requirement within the vendor's established pharmaceutical supply relationship with the VA healthcare system.
Quick answers
Who was awarded contract 36C26125N0755?
36C26125N0755 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on September 23, 2025.
How much is contract 36C26125N0755 worth?
The government has obligated $19,746 on 36C26125N0755.
Is contract 36C26125N0755 an order under another contract?
Yes. 36C26125N0755 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26125N0755 competed?
The extent of competition for 36C26125N0755 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award